By Neena Bhandari
Melbourne, 29.10.2008 (IANS): Australia will need to look beyond the United States and Europe to translate its expertise in basic research into inventing drugs and a cost-effective India can help fill the gap especially in the current economic scenario, says the CEO of an Indian biotech firm.
“Australia has phenomenal strength in basic research in early drug discovery and identifying disease targets. My perception is to somehow translate this early drug discovery into identifying drug candidates for pre-clinical trials and clinical trials, wherein lies India’s strength,” Rashmi H. Barbhaiya, founder and CEO of Bangalore-based Advinus Therapeutics Pvt Ltd, told IANS.